Therapeutic effects of anti-GM2 CAR-T cells expressing IL-7 and CCL19 for GM2-positive solid cancer in xenograft model.
Takahiro SasakiYukimi SakodaKeishi AdachiYoshihiro TokunagaKoji TamadaPublished in: Cancer medicine (2023)
Our study revealed the promising therapeutic efficacy of anti-GM2 IL-7/CCL19-producing human CAR-T cells with an enhanced safety for clinical application in the treatment of patients with GM2-positive solid cancers.